Shares fell more than 8% in premarket trading. The company said it was halting the development program in light of disappointing preclinical studies. Shares fell more than 8% in premarket trading. The ...

-- Response to COVID-19 pandemic anticipated to cause interruptions in certain clinical trial operations; updated interim data readout timing to be provided at later date -- “Our priority is always ...

‘The biggest challenge MSPs have has never been selling Microsoft products, it’s understanding Microsoft itself. We’re here to translate Microsoft to human,’ says Alexandre Laflamme, programs and ...